Industry News
Why do cells age? Discovery of extremely long-lived proteins may provide insight into cell aging and neurodegenerative diseases
One of the big mysteries in biology is why cells age. Now scientists report that they have discovered a weakness in a component of brain cells that may explain how the aging process occurs in the brain.
A lonely heart can make you sick: Middle aged divorced women vulnerable to contracting HIV
Newly divorced middle aged women are more vulnerable to contract HIV and other sexually transmitted diseases, according to new research, because they tend to let their guard down with new sexual partners and avoid using protection since they are not afraid of getting pregnant.
The complex relationship between memory and silence
People who suffer a traumatic experience often don't talk about it, and many forget it over time. But not talking about something doesn't always mean you'll forget it; if you try to force yourself not to think about white bears, soon you'll be imagining polar bears doing the polka. A group of psychological scientists explore the relationship between silence and memories.
Schooling protects refugee children from disease
Refugee children have scant access to medical care and are particularly vulnerable to disease. Fresh research results show that just a few hours of schooling a week may have a pronounced positive impact on their health not only in childhood but later in life when they achieve adulthood.
Placebos and distraction: New study shows how to boost the power of pain relief, without drugs
Placebos reduce pain by creating an expectation of relief. Distraction -- say, doing a puzzle -- relieves it by keeping the brain busy. But do they use the same brain processes? Neuromaging suggests they do. When applying a placebo, scientists see activity in the dorsolateral prefrontal cortex. That's the part of the brain that controls high-level cognitive functions like working memory and attention -- which is what you use to do that distracting puzzle.
Rare mutations may help explain aneurysm in high-risk families
An innovative approach to genome screening has provided clues about rare mutations that may make people susceptible to brain aneurysms, predisposing them to brain bleeds, according to preliminary research.
Warfarin and aspirin are similar in heart failure treatment, study suggests
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to new research.
New hope for patients with brain tumors
In the United States, each year, approximately 10,000 patients are affected by recurrent glioblastoma multiforme. Now, a novel investigational device – available only at clinical trial sites – is offering new hope to these patients.
New drug doesn't improve disability among stroke patients, researchers find
A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to new research.
Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding and death, researchers report
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke, according to new research.